Tectonic Therapeutic to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in fireside chats at the upcoming Stifel 2026 Healthcare Conference, and the Piper Sandler 38 th Annual Healthcare Conference.